HealthcareServices

Stem Cell Cryopreservation Market 2026–2030: Forecast, Innovation, and Competitive Trends

March 3, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the stem cell cryopreservation market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Stem Cell Cryopreservation Market expected to grow between 2026 and 2030?

The stem cell cryopreservation market has experienced rapid expansion in recent years. Its valuation is projected to rise from $4.17 billion in 2025 to $4.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 19.8%. Historically, this growth can be ascribed to factors such as the proliferation of stem cell banking initiatives, the increasing utilization of cryopreservation in research, the growth in IVF and fertility treatments, the rising demand for long-term cell storage, and improvements in cryogenic storage technologies.

The stem cell cryopreservation market size is anticipated to undergo significant expansion in the next few years. It is projected to reach $10.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 19.5%. This growth during the forecast period is attributed to the increasing uptake of regenerative medicine therapies, rising investments in biobanking infrastructure, a growing need for personalized medicine storage solutions, the broadening of clinical cell therapy pipelines, and a heightened focus on standardized storage protocols. Key trends for the forecast period include an escalating demand for long-term stem cell storage, increased adoption of advanced cryoprotectants, a rising implementation of automated cryopreservation systems, the expansion of stem cell banking services, and an enhanced emphasis on preserving cell viability.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30405&type=smp

Which Drivers Are Influencing Market Acceleration In The Stem Cell Cryopreservation Market?

The rising occurrence of degenerative diseases is anticipated to drive the expansion of the stem cell cryopreservation market in the future. Degenerative diseases are health conditions characterized by the gradual decline in the structure or function of tissues or organs, frequently resulting in impaired normal functionality. The growing incidence of degenerative diseases stems from the expanding elderly population, given that older individuals are more prone to cellular and tissue decay contributing to these ailments. Stem cell cryopreservation facilitates the extended preservation of living stem cells, offering a dependable supply for regenerative treatments aimed at mending and substituting compromised tissues in degenerative conditions. To illustrate, in March 2023, data from the Alzheimer’s Association, a US-based nonprofit voluntary health organization, indicated that around 6.7 million Americans aged 65 and older were suffering from Alzheimer’s dementia, with projections showing this figure increasing to 13.8 million by 2060. Consequently, the rising occurrence of degenerative diseases is fueling the expansion of the stem cell cryopreservation market.

What Leading Segments Are Studied In The Stem Cell Cryopreservation Market?

The stem cell cryopreservation market covered in this report is segmented –

1) By Type: Embryonic Stem Cell, Adult Stem Cell, Induced Pluripotent Stem Cell

2) By Application: Cell Freezing Media, Equipment And Consumables

3) By End User: Biopharmaceutical Companies, Research Institutes, Blood Banks, In Vitro Fertilization (IVF) Clinics

Subsegments:

1) By Embryonic Stem Cell: Human Embryonic Stem Cell, Mouse Embryonic Stem Cell, Primate Embryonic Stem Cell, Other Embryonic Stem Cells

2) By Adult Stem Cell: Hematopoietic Stem Cell, Mesenchymal Stem Cell, Neural Stem Cell, Epithelial Stem Cell

3) By Induced Pluripotent Stem Cell: Fibroblast-Derived iPSC, Blood Cell-Derived iPSC, Epithelial Cell-Derived iPSC

What Upcoming Trends Are Likely To Define The Future Path Of The Stem Cell Cryopreservation Market?

Major companies in the stem cell cryopreservation market are concentrating on developing innovative solutions, such as advanced cryopreservation media and automation-friendly freezing systems, to boost post-thaw cell viability and accelerate stem cell therapy development. Advanced cryopreservation media are specifically formulated solutions designed to safeguard stem cells during freezing and thawing, thereby maintaining their viability and function. Automation-friendly freezing systems, conversely, are equipment or processes engineered for scalable, reproducible, and hands-free cell freezing in large-scale manufacturing. For example, in April 2024, Pluristyx, Inc., a US-based biotechnology company, introduced PluriFreeze, a proprietary cryopreservation medium. This sophisticated solution is engineered to enhance the freezing and thawing of pluripotent stem cells and other sensitive cell types, ensuring superior post-thaw viability and functional integrity. Featuring an entirely synthetic, animal-origin-free formulation with low viscosity, PluriFreeze is ideal for automated and large-scale cell production. It is complemented by the DMSO-free PluriPrep wash solution, which permits extended processing times. Made from Generally Recognized as Safe (GRAS) components, the medium offers consistent, dependable, and secure cryopreservation for both research and clinical applications. By seamlessly integrating with platforms such as PluriBank, this launch strengthens the stem cell cryopreservation workflow, providing efficient and scalable solutions from initial laboratory research through to clinical implementation.

Which Key Market Players Are Investing In Expansion And Innovation Within The Stem Cell Cryopreservation Market?

Major companies operating in the stem cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group Ltd., Sartorius AG, Eppendorf SE, Vitalant Inc., BioLife Solutions Inc., Cryoviva Biotech Private Limited., HiMedia Laboratories Private Limited, Cryo-Cell International Inc., Celularity Inc., PromoCell GmbH, Creative Biolabs Inc., StemCyte Inc., Reprocell Inc., OriGen Biomedical Inc., American CryoStem Corporation, Ossium Health Inc., Pluristyx Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-cryopreservation-market-report

Which Regions Are Poised For Strategic Growth In The Stem Cell Cryopreservation Market?

North America was the largest region in the stem cell cryopreservation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell cryopreservation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Stem Cell Cryopreservation Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30405&type=smp

Browse Through More Reports Similar to the Global Stem Cell Cryopreservation Market 2026, By The Business Research Company

Cell Regeneration Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-regeneration-medicine-global-market-report

Cryoablation Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cryoablation-devices-global-market-report

Stem Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795